Primex_ADV6209_girl_h

News

May 31, 2018

Primex participates in European Society of Anesthesiology Congress in Copenhagen 2-4th June

Primex Pharmaceuticals invites all the Euroanaesthesia 2018 delegates to join the ESA 2018 Industry Sponsored Symposium: Paediatric Sedation: Are There Areas for Improvement? on Sunday 3rd of June at 12:00.

Register to live stream Primex Pharmaceuticals industry sponsored symposium from here.

Primex Pharmaceuticals with the support of TheSi Farma, launch OZASED® in Italy

OZALIN® continues to receive marketing authorization approvals across EU

Primex Pharmaceuticals and Nordic Group sign a strategic partnership to commercialise OZALIN® in France

Primex Pharmaceuticals and POA Pharma sign a strategic partnership to commercialise OZALIN in the Nordic region.

Primex Pharmaceuticals AG announces it has received marketing authorization (MA) in the EU for OZALIN®

Primex Pharmaceuticals Appoints Tomaso Dameno as Head of Operations

Primex Pharmaceuticals AG presents ADV6209* at Euroanaesthesia 2018